Only the monthly chart is worth watching for long term holders and it is clearly showing aggressive uptrend in the 10 year cycle.
36 month MA crossed the 60 month MA several weeks ago and is diverging as expected. Short term trading opportunities possibly, but with far more risk than sitting on this horse and waiting for MSB to deliver multiple opportunities, including a very fair chance of COVID19 therapy.
So technically on the major monthly chart we have:
- Back test at old tops completed
- 10 year cycle
- Major MAs in sync and diverging
- Quad bottoms
- Volume rising
- RSI still in neutral zone
- MACD expanding
Everyone knows the fundamentals!
No gaurantee's only probabilities for an investment framework.
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-829
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |